| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $13,482,322 | 32 | 100 |
| Uychiat Pison Marivic | director | 0 | $0 | 3 | $44,536 | $-44,536 |
| Parkinson Mark Vincent | director | 0 | $0 | 4 | $74,234 | $-74,234 |
| Blouin Ann Scott | director | 0 | $0 | 2 | $143,079 | $-143,079 |
| Agwunobi John O | director | 0 | $0 | 5 | $262,175 | $-262,175 |
| Shaw Daren | director | 0 | $0 | 2 | $392,000 | $-392,000 |
| SMITH BARRY M | director | 0 | $0 | 8 | $1.03M | $-1.03M |
| Wittekind Beverly B. | VP and Chief Legal Officer | 0 | $0 | 3 | $1.94M | $-1.94M |
| Burton Spencer | President and COO | 0 | $0 | 3 | $2.11M | $-2.11M |
| Snapper Suzanne D. | CFO | 0 | $0 | 2 | $2.5M | $-2.5M |
| Port Barry | Chief Executive Officer | 0 | $0 | 1 | $5.12M | $-5.12M |
The Ensign Group, Inc. operates as a healthcare provider, primarily concentrating on post-acute care services, alongside other supporting business ventures. The company's activities are organized into two main divisions: Skilled Services and Real Estate. Within its Skilled Services segment, Ensign provides extensive short-term and long-term nursing care tailored for patients recovering from extended illnesses, managing chronic health conditions, or requiring elder care. This division also encompasses a variety of rehabilitative therapies, such …
Over the last 12 months, insiders at The Ensign Group, Inc. have bought $0 and sold $13.48M worth of The Ensign Group, Inc. stock.
On average, over the past 5 years, insiders at The Ensign Group, Inc. have bought $18 and sold $14.98M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 0 shares for transaction amount of $18 was made by Agwunobi John O (director) on 2024‑04‑30.
| 2026-10-16 | Sale | Parkinson Mark Vincent | director | 100 0.0002% | $179.62 | $17,962 | +0.57% | |
| 2026-07-27 | Sale | Blouin Ann Scott | director | 375 0.0007% | $183.54 | $68,829 | -1.20% | |
| 2026-07-20 | Sale | Agwunobi John O | director | 392 0.0007% | $171.06 | $67,056 | +2.06% | |
| 2026-07-16 | Sale | Parkinson Mark Vincent | director | 100 0.0002% | $168.12 | $16,812 | +1.53% | |
| 2026-06-02 | Sale | SMITH BARRY M | director | 700 0.0012% | $164.28 | $114,996 | +4.44% | |
| 2026-05-04 | Sale | SMITH BARRY M | director | 700 0.0012% | $182.21 | $127,547 | -4.93% | |
| 2026-04-20 | Sale | Agwunobi John O | director | 392 0.0007% | $199.97 | $78,388 | -12.21% | |
| 2026-04-16 | Sale | Parkinson Mark Vincent | director | 100 0.0002% | $196.60 | $19,660 | -12.19% | |
| 2026-04-02 | Sale | SMITH BARRY M | director | 700 0.0012% | $196.65 | $137,655 | -11.29% | |
| 2026-03-02 | Sale | SMITH BARRY M | director | 700 0.0012% | $213.02 | $149,114 | -18.41% | |
| 2026-02-20 | Sale | Uychiat Pison Marivic | director | 67 0.0001% | $204.92 | $13,730 | -16.23% | |
| 2026-02-19 | Sale | Wittekind Beverly B. | VP and Chief Legal Officer | 500 0.0009% | $210.23 | $105,115 | -13.83% | |
| 2026-02-19 | Sale | Uychiat Pison Marivic | director | 83 0.0001% | $211.02 | $17,514 | -13.83% | |
| 2026-02-17 | Sale | Shaw Daren | director | 1,000 0.0017% | $213.43 | $213,430 | -16.88% | |
| 2026-02-09 | Sale | Blouin Ann Scott | director | 375 0.0006% | $198.00 | $74,250 | -11.16% | |
| 2026-02-09 | Sale | Parkinson Mark Vincent | director | 100 0.0002% | $198.00 | $19,800 | -11.16% | |
| 2026-02-06 | Sale | Snapper Suzanne D. | CFO | 4,573 0.0078% | $196.11 | $896,823 | -10.41% | |
| 2026-02-05 | Sale | Snapper Suzanne D. | CFO | 8,258 0.0141% | $194.48 | $1.61M | -10.04% | |
| 2026-02-02 | Sale | SMITH BARRY M | director | 700 0.0012% | $171.54 | $120,078 | +2.69% | |
| 2026-01-21 | Sale | Agwunobi John O | director | 146 0.0003% | $178.31 | $26,033 | -0.72% |
| Snapper Suzanne D. | CFO | 272889 0.4678% | $49.72M | 1 | 61 | +80.41% |
| Agwunobi John O | director | 9503 0.0163% | $1.73M | 1 | 5 | +14.7% |
| Nackel John G. | 70982 0.1217% | $12.93M | 10 | 32 | +20.65% | |
| Daniels Lee A | director | 47504 0.0814% | $8.66M | 2 | 19 | +37.69% |
| Christensen Christopher R. | Executive Chairman | 12539 0.0215% | $2.28M | 2 | 79 | +81.95% |
| Increased Positions | 300 | +55.05% | 5M | +8.27% |
| Decreased Positions | 227 | -41.65% | 5M | -9.03% |
| New Positions | 102 | New | 775,582 | New |
| Sold Out Positions | 36 | Sold Out | 173,638 | Sold Out |
| Total Postitions | 618 | +13.39% | 54M | -0.76% |
| Blackrock, Inc. | $1.23M | 12.15% | 7.05M | -152,623 | -2.12% | 2025-09-30 |
| Vanguard Group Inc | $1.06M | 10.47% | 6.07M | -58,300 | -0.95% | 2025-09-30 |
| Wasatch Advisors Lp | $614,517.00 | 6.09% | 3.53M | -25,342 | -0.71% | 2025-09-30 |
| Baillie Gifford & Co | $490,212.00 | 4.86% | 2.82M | +1M | +96.2% | 2025-09-30 |
| Fmr Llc | $453,532.00 | 4.5% | 2.61M | -99,728 | -3.68% | 2025-09-30 |
| State Street Corp | $355,997.00 | 3.53% | 2.05M | -31,757 | -1.53% | 2025-09-30 |
| Capital Research Global Investors | $350,640.00 | 3.48% | 2.02M | +136,260 | +7.25% | 2025-09-30 |
| Geode Capital Management, Llc | $252,107.00 | 2.5% | 1.45M | +12,271 | +0.85% | 2025-09-30 |
| Price T Rowe Associates Inc /Md/ | $211,208.00 | 2.09% | 1.21M | +622,690 | +105.24% | 2025-09-30 |
| Fuller & Thaler Asset Management, Inc. | $193,307.00 | 1.92% | 1.11M | -88,708 | -7.39% | 2025-09-30 |